the others study: optimal duration of checkpoint inhibitors in solid tumors
Published 1 year ago • 82 plays • Length 0:53Download video MP4
Download video MP3
Similar videos
-
0:37
the future of adapt-001 in patients with solid tumors refractory to checkpoint inhibitors
-
45:59
immune checkpoint inhibitors in solid tumours
-
1:05
limitations in immune checkpoint inhibitors in treating gastric cancer
-
0:55
enhancing the efficacy of immune checkpoint inhibitors in crc
-
3:18
immune checkpoint inhibitors and combination strategies for patients with gastric cancer
-
58:49
curing metastatic solid tumours with immune checkpoint inhibitors by professor james larkin
-
8:17
immune checkpoint inhibitors
-
15:51
introduction to immunotherapy (immunotherapy documentary part i)
-
5:30
expert report on immune checkpoint inhibitors for dmmr colorectal cancer
-
1:58
dr. weber on duration of checkpoint inhibitor therapy in melanoma
-
27:43
targeting the immune system with checkpoint inhibitors
-
9:54
duration of checkpoint inhibitor therapy
-
1:45
mechanisms of resistance to checkpoint inhibitors in melanoma
-
1:02
how useful are checkpoint inhibitors in the treatment of breast cancer?
-
1:23
the role of immune checkpoint inhibitors in mcrpc
-
1:44
immune checkpoint inhibitors in mcrpc
-
1:01:45
immune checkpoint inhibitors: the good, the bad, and the emerging field of cardio-oncology
-
3:10
targeted therapy or checkpoint inhibitors in melanoma: which is better?
-
3:16
checkpoint inhibitors - alone or with chemotherapy in lung cancer?
-
4:36
efficacy and safety of checkpoint inhibitors in lung cancer
-
3:30
side effects of immune checkpoint inhibitors
-
1:33
dr. maurie markman developing research into checkpoint inhibitors in ovarian cancer